PetMed Express Announces Director Departure, Officer Compensation
Ticker: PETS · Form: 8-K · Filed: Aug 12, 2025 · CIK: 1040130
| Field | Detail |
|---|---|
| Company | Petmed Express Inc (PETS) |
| Form Type | 8-K |
| Filed Date | Aug 12, 2025 |
| Risk Level | low |
| Pages | 8 |
| Reading Time | 10 min |
| Key Dollar Amounts | $550,000, $425,000, $50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-departure, officer-compensation, corporate-governance
Related Tickers: PETS
TL;DR
PETS director Zalesin out, exec comp details, and financials filed.
AI Summary
PetMed Express, Inc. announced on August 11, 2025, the departure of Director Steven R. Zalesin. The company also reported on compensatory arrangements for certain officers and provided a Regulation FD disclosure. Additionally, the filing includes financial statements and exhibits.
Why It Matters
Changes in directorship and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance and disclosures, with no immediate financial distress or significant operational changes indicated.
Key Players & Entities
- Steven R. Zalesin (person) — Departing Director
- PetMed Express, Inc. (company) — Registrant
- August 11, 2025 (date) — Date of earliest event reported
FAQ
Who is Steven R. Zalesin and what was his role at PetMed Express?
Steven R. Zalesin was a Director at PetMed Express, Inc., and his departure was reported on August 11, 2025.
What specific items are covered in this 8-K filing?
This 8-K filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD disclosures, other events, and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on August 11, 2025.
What is the principal executive office address for PetMed Express, Inc.?
The principal executive offices of PetMed Express, Inc. are located at 420 South Congress Avenue, Delray Beach, Florida 33445.
What is the telephone number for PetMed Express, Inc.?
The telephone number for PetMed Express, Inc. is (561) 526-4444.
Filing Stats: 2,375 words · 10 min read · ~8 pages · Grade level 11.3 · Accepted 2025-08-12 16:20:55
Key Financial Figures
- $550,000 — ntinuation of her annual base salary of $550,000 for a period of 13 months and reimburse
- $425,000 — ntinuation of her annual base salary of $425,000 for a period of 13 months and reimburse
- $50 — omplaints; a fiscal fourth quarter 2025 $50 coupon promotion to customers and its p
Filing Documents
- pets-20250811.htm (8-K) — 47KB
- pets-camposexecseparationa.htm (EX-10.1) — 60KB
- pets-deliaexecseparationag.htm (EX-10.2) — 56KB
- pets-20250812xexx991pressr.htm (EX-99.1) — 9KB
- 0001040130-25-000049.txt ( ) — 365KB
- pets-20250811.xsd (EX-101.SCH) — 2KB
- pets-20250811_def.xml (EX-101.DEF) — 16KB
- pets-20250811_lab.xml (EX-101.LAB) — 27KB
- pets-20250811_pre.xml (EX-101.PRE) — 16KB
- pets-20250811_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On August 12, 2025, the Company issued a press release announcing the management changes described in Item 5.02 of this Current Report on Form 8-K. A copy of this press release is furnished with this report as Exhibit 99.1 and incorporated herein by reference. The information in this Item 7.01 and the related information in Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth by specific reference in such filing.
01 Other Events
Item 8.01 Other Events. As disclosed in a Current Report on Form 8-K filed by the Company on July 1, 2025, the Company's Audit Committee, with the aid of external legal counsel and other external advisors, is investigating certain anonymous whistleblower hotline reports received by the Audit Committee regarding the timing of revenue recognition with respect to certain autoship orders in the fiscal fourth quarter of 2025, some of which resulted in customer complaints; a fiscal fourth quarter 2025 $50 coupon promotion to customers and its potential impact on Company key-performance indicators (KPIs) regarding new customers; and the Company's culture and control environment. The Audit Committee's investigation is ongoing, and the Audit Committee is working diligently to complete its investigation as soon as practicable.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Separation Agreement, dated August 11, 2025, between the Company and Sandra Campos. 10.2 Separation Agreement, dated August 11, 2025, between the Company and Robyn D'Elia. 99.1 Press Release dated A ugust 12 , 2025 104 Cover Page Interactive Data File (formatted as Inline XBRL) * * * 4
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 12, 2025 PETMED EXPRESS, INC. By: /s/ Robert Lawsky Name: Robert Lawsky Title: General Counsel 5